GLP-1 based therapeutics: simultaneously combating T2DM and obesityKristy M. Heppner(Oregon National Primate Research Center), Diego Pérez–Tilve(University of Cincinnati Medical Center)Frontiers in NeuroscienceMarch 20, 201510.3389/fnins.2015.00092Cited by 116SaveCiteExport RISWatch citationsRelated PapersExpression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (<i>Macaca mulatta</i>) Brain|Endocrinology|2014|193Chemogenetic engagement of different GPCR signaling pathways segregates the orexigenic activity from the control of whole-body glucose metabolism by AGRP neurons|Molecular Metabolism|2024|3